Soufla Giannoula, Sifakis Stavros, Spandidos Demetrios A
Department of Virology, Medical School, University of Crete, PO Box 1527, Heraklion 71003, Crete, Greece.
Cancer Lett. 2008 Feb 8;259(2):146-55. doi: 10.1016/j.canlet.2007.10.002. Epub 2007 Nov 19.
Epidermal and insulin-like growth factors (EGF, IGFs) act as mitogens promoting endothelial cell proliferation and differentiation. Accumulating evidence for interactions between EGF and IGF signaling pathways has been reported. Fibroblast growth factor-2 (FGF2) is also mitogenic for various cell types and is associated with regulation of tumor angiogenesis and metastasis. However EGF, IGF-1 and FGF2 transcript levels have been scarcely investigated in endometrial carcinoma.
In the present study, we evaluated the mRNA expression pattern of EGF, IGF-1 and FGF2 by using Comparative Quantitative real-time RT-PCR assay in 30 endometrial cancer specimens and an equal number of adjacent normal tissues.
Both overexpression and down-regulation of EGF, IGF-1 and FGF2 was demonstrated in endometrial cancer compared to the adjacent normal specimens; however the main features of cancer were IGF-1 and EGF down-regulation and FGF2 up-regulation. Different co-expression patterns of all three factors were displayed in normal and malignant endometrium. Interestingly, FGF2 mRNA was positively correlated with EGF and IGF-1 transcript levels in endometrial cancer (P=0.024 and P=0.006, respectively), while no co-expression was observed in the adjacent normal specimens. Furthermore, endometrial tissue-pair analysis revealed a significant positive correlation between EGF and IGF-1 (P=0.010), supporting the hypothesis of a cross-talk between IGF- and EGF-mediated signaling pathways in endometrial cancer. EGF transcript levels were marginally higher in endometrioid than non-endometrioid tumors (P=0.050), and in grade I compared to grade II tumors (P=0.053).
Up-regulation as well as down-regulation of EGF, IGF-1 and FGF2 transcript levels is observed in endometrial cancer; however IGF-1 and EGF down-regulation and FGF2 up-regulation seem to comprise the main features of endometrial carcinogenesis. The disruption of their mRNA co-expression pattern observed supports the hypothesis of a cross-talk between IGF- and EGF-mediated signaling pathways in promoting endothelial cell proliferation and differentiation in endometrial cancer.
表皮生长因子和胰岛素样生长因子(EGF、IGFs)作为有丝分裂原,可促进内皮细胞增殖和分化。已有越来越多的证据表明EGF和IGF信号通路之间存在相互作用。成纤维细胞生长因子-2(FGF2)对多种细胞类型也有促有丝分裂作用,并与肿瘤血管生成和转移的调控有关。然而,在子宫内膜癌中,EGF、IGF-1和FGF2的转录水平鲜有研究。
在本研究中,我们采用比较定量实时逆转录聚合酶链反应(RT-PCR)法,对30例子宫内膜癌标本及等量的相邻正常组织中EGF、IGF-1和FGF2的mRNA表达模式进行了评估。
与相邻正常标本相比,子宫内膜癌中EGF、IGF-1和FGF2均有过表达和下调现象;然而,癌症的主要特征是IGF-1和EGF下调以及FGF2上调。在正常和恶性子宫内膜中,这三种因子呈现出不同的共表达模式。有趣的是,在子宫内膜癌中,FGF2 mRNA与EGF和IGF-1转录水平呈正相关(分别为P=0.024和P=0.006),而在相邻正常标本中未观察到共表达。此外,子宫内膜组织配对分析显示EGF和IGF-1之间存在显著正相关(P=0.010),支持了IGF和EGF介导的信号通路在子宫内膜癌中存在相互作用的假说。在子宫内膜样癌中,EGF转录水平略高于非子宫内膜样肿瘤(P=0.050),在I级肿瘤中高于II级肿瘤(P=0.053)。
在子宫内膜癌中观察到EGF、IGF-1和FGF2转录水平的上调以及下调;然而,IGF-1和EGF下调以及FGF2上调似乎是子宫内膜癌发生的主要特征。观察到的它们mRNA共表达模式的破坏支持了IGF和EGF介导的信号通路在促进子宫内膜癌内皮细胞增殖和分化过程中存在相互作用的假说。